BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malmer BS, Feychting M, Lönn S, Lindström S, Grönberg H, Ahlbom A, Schwartzbaum J, Auvinen A, Collatz-Christensen H, Johansen C, Kiuru A, Mudie N, Salminen T, Schoemaker MJ, Swerdlow AJ, Henriksson R. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol 2007;82:229-37. [PMID: 17151932 DOI: 10.1007/s11060-006-9275-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Patil P, Pencheva BB, Patil VM, Fangusaro J. Nervous system (NS) Tumors in Cancer Predisposition Syndromes. Neurotherapeutics 2022. [PMID: 36056180 DOI: 10.1007/s13311-022-01277-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Montazeri-Najababady N, Dabbaghmanesh MH, Nasimi N, Sohrabi Z, Chatrabnous N. The association between TP53 rs1625895 polymorphism and the risk of sarcopenic obesity in Iranian older adults: a case-control study. BMC Musculoskelet Disord 2021;22:438. [PMID: 33985476 DOI: 10.1186/s12891-021-04314-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Bulsara KR, Moskalik AD, Knopf J, Calafiore R. Non-endocrine Neoplasms of the Hypothalamus. The Human Hypothalamus 2021. [DOI: 10.1007/978-3-030-62187-2_16] [Reference Citation Analysis]
4 Fischer I, Mijderwijk HJ, Kahlert UD, Rapp M, Sabel M, Hänggi D, Steiger HJ, Forster MT, Kamp MA. Association between health insurance status and malignant glioma. Neurooncol Pract 2020;7:531-40. [PMID: 33014394 DOI: 10.1093/nop/npaa030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Shen CC, Cheng WY, Lee CH, Dai XJ, Chiao MT, Liang YJ, Hsieh WY, Mao TF, Lin GS, Chen SR, Liu BS, Chen JP. Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment. BMC Cancer 2020;20:709. [PMID: 32727419 DOI: 10.1186/s12885-020-07210-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mobark NA, Alharbi M, Alhabeeb L, AlMubarak L, Alaljelaify R, AlSaeed M, Almutairi A, Alqubaishi F, Ahmad M, Al-Banyan A, Alotabi FE, Barakeh D, AlZahrani M, Al-Khalidi H, Ajlan A, Ramkissoon LA, Ramkissoon SH, Abedalthagafi M. Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia. PLoS One 2020;15:e0228356. [PMID: 31995621 DOI: 10.1371/journal.pone.0228356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Georgescu MM, Nanda A, Li Y, Mobley BC, Faust PL, Raisanen JM, Olar A. Mutation Status and Epithelial Differentiation Stratify Recurrence Risk in Chordoid Meningioma-A Multicenter Study with High Prognostic Relevance. Cancers (Basel) 2020;12:E225. [PMID: 31963394 DOI: 10.3390/cancers12010225] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
8 Khan AU, Mahjabeen I, Malik MA, Hussain MZ, Khan S, Kayani MA. Modulation of brain tumor risk by genetic SNPs in PARP1gene: Hospital based case control study. PLoS One 2019;14:e0223882. [PMID: 31609976 DOI: 10.1371/journal.pone.0223882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Assad Samani L, Javadirad SM, Parsafar S, Tabatabaeian H, Ghaedi K, Azadeh M. TP53 rs1625895 is Related to Breast Cancer Incidence and Early Death in Iranian Population. Indian J Clin Biochem 2019;34:485-9. [PMID: 31686737 DOI: 10.1007/s12291-018-0774-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Baldi I, Engelhardt J, Bonnet C, Bauchet L, Berteaud E, Grüber A, Loiseau H. Epidemiology of meningiomas. Neurochirurgie 2018;64:5-14. [DOI: 10.1016/j.neuchi.2014.05.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 15.8] [Reference Citation Analysis]
11 Romano FJ, Guadagno E, Solari D, Borrelli G, Pignatiello S, Cappabianca P, Del Basso De Caro M. ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study. J Cell Biochem 2018;119:4867-77. [PMID: 29369420 DOI: 10.1002/jcb.26699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 Estiar MA, Mehdipour P. ATM in breast and brain tumors: a comprehensive review. Cancer Biol Med 2018;15:210-27. [PMID: 30197789 DOI: 10.20892/j.issn.2095-3941.2018.0022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
13 Lavrador JP, Pinto MV, Lemos LM, Ribeiro C, Santos AP. Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer. J Neurooncol 2018;136:163-71. [DOI: 10.1007/s11060-017-2640-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
14 Mawrin C. [Hereditary tumor syndromes in neuropathology]. Pathologe 2017;38:186-96. [PMID: 28474160 DOI: 10.1007/s00292-017-0292-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Vijapura C, Saad Aldin E, Capizzano AA, Policeni B, Sato Y, Moritani T. Genetic Syndromes Associated with Central Nervous System Tumors. RadioGraphics 2017;37:258-80. [DOI: 10.1148/rg.2017160057] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
16 Jin Y, Xiao W, Song T, Feng G, Dai Z. Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis. Neurochem Res 2016;41:1723-31. [PMID: 27038932 DOI: 10.1007/s11064-016-1888-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
17 Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M. Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus 2015;38:E6. [PMID: 25552286 DOI: 10.3171/2014.10.FOCUS12367] [Cited by in Crossref: 222] [Cited by in F6Publishing: 240] [Article Influence: 31.7] [Reference Citation Analysis]
18 Magi A, D'Aurizio R, Palombo F, Cifola I, Tattini L, Semeraro R, Pippucci T, Giusti B, Romeo G, Abbate R, Gensini GF. Characterization and identification of hidden rare variants in the human genome. BMC Genomics 2015;16:340. [PMID: 25903059 DOI: 10.1186/s12864-015-1481-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
19 Khan MH, Khalil A, Rashid H. Evaluation of the p53 Arg72Pro polymorphism and its association with cancer risk: a HuGE review and meta-analysis. Genet Res (Camb) 2015;97:e7. [PMID: 25882871 DOI: 10.1017/S0016672315000075] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
20 Zeng XT, Lu JT, Tang XJ, Weng H, Luo J. Association of methionine synthase rs1801394 and methionine synthase reductase rs1805087 polymorphisms with meningioma in adults: A meta-analysis. Biomed Rep 2014;2:432-6. [PMID: 24748989 DOI: 10.3892/br.2014.248] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
21 Adel Fahmideh M, Schwartzbaum J, Frumento P, Feychting M. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncol 2014;16:807-14. [PMID: 24500421 DOI: 10.1093/neuonc/nou003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
22 Zhu W, Lu L, Li Y, Yao J, Xu B. The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis. Tumor Biol 2014;35:3725-30. [DOI: 10.1007/s13277-013-1494-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
23 Debata PR, Curcio GM, Mukherjee S, Banerjee P. Causal Factors for Brain Tumor and Targeted Strategies. In: Freund F, Langhoff S, editors. Universe of Scales: From Nanotechnology to Cosmology. Cham: Springer International Publishing; 2014. pp. 191-204. [DOI: 10.1007/978-3-319-02207-9_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Damiola F, Byrnes G, Moissonnier M, Pertesi M, Deltour I, Fillon A, Le Calvez-kelm F, Tenet V, Mckay-chopin S, Mckay JD, Malakhova I, Masyakin V, Cardis E, Lesueur F, Kesminiene A. Contribution of ATM and FOXE1 ( TTF2 ) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation: ATM , FOXE1 and Radiation-Related PTC in Belarusia. Int J Cancer 2014;134:1659-68. [DOI: 10.1002/ijc.28483] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
25 Zhang F, Li D, Li Y, Li H, Sun J, Li X, Li X. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma. Tumor Biol 2014;35:747-51. [DOI: 10.1007/s13277-013-1101-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
26 He F, Xia Y, Liu H, Li J, Wang C. P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis. Tumor Biol 2013;34:3121-30. [DOI: 10.1007/s13277-013-0880-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
27 Toptaş B, Kafadar AM, Cacina C, Turan S, Yurdum LM, Yiğitbaşı N, Gökçe MO, Zeybek U, Yaylım I. The vitamin D receptor (VDR) gene polymorphisms in Turkish brain cancer patients. Biomed Res Int 2013;2013:295791. [PMID: 23691496 DOI: 10.1155/2013/295791] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
28 Giles GG. Epidemiology of brain tumors. Brain Tumors 2012. [DOI: 10.1016/b978-0-443-06967-3.00004-1] [Reference Citation Analysis]
29 Shen L, Yin ZH, Wan Y, Zhang Y, Li K, Zhou BS. Association between ATM polymorphisms and cancer risk: a meta-analysis. Mol Biol Rep 2012;39:5719-25. [PMID: 22203481 DOI: 10.1007/s11033-011-1381-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
30 Shi M, Huang R, Pei C, Jia X, Jiang C, Ren H. TP53 codon 72 polymorphism and glioma risk: A meta-analysis. Oncol Lett 2012;3:599-606. [PMID: 22740959 DOI: 10.3892/ol.2011.521] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
31 Dorward IG, Leonard JR. Familial Tumors (Neurocutaneous Syndromes). Youmans Neurological Surgery. Elsevier; 2011. pp. 2128-35. [DOI: 10.1016/b978-1-4160-5316-3.00208-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010;99:307-14. [PMID: 20821343 DOI: 10.1007/s11060-010-0386-3] [Cited by in Crossref: 638] [Cited by in F6Publishing: 680] [Article Influence: 53.2] [Reference Citation Analysis]
33 Andersson U, Schwartzbaum J, Wiklund F, Sjöström S, Liu Y, Tsavachidis S, Ahlbom A, Auvinen A, Collatz-Laier H, Feychting M, Johansen C, Kiuru A, Lönn S, Schoemaker MJ, Swerdlow AJ, Henriksson R, Bondy M, Melin B. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol 2010;49:767-75. [PMID: 20446891 DOI: 10.3109/0284186X.2010.480980] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
34 Sjöström S, Andersson U, Liu Y, Brännström T, Broholm H, Johansen C, Collatz-Laier H, Henriksson R, Bondy M, Melin B. Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro Oncol 2010;12:815-21. [PMID: 20197289 DOI: 10.1093/neuonc/noq018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
35 Kheirollahi M, Mehr-Azin M, Kamalian N, Mehdipour P. Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors. Med Oncol 2011;28:7-14. [PMID: 20077038 DOI: 10.1007/s12032-009-9412-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
36 Calvocoressi L, Claus EB. Epidemiology and Natural History of Meningiomas. Meningiomas 2010. [DOI: 10.1016/b978-1-4160-5654-6.00004-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Andersson U, Osterman P, Sjöström S, Johansen C, Henriksson R, Brännström T, Broholm H, Christensen HC, Ahlbom A, Auvinen A, Feychting M, Lönn S, Kiuru A, Swerdlow A, Schoemaker M, Roos G, Malmer B. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer 2009;125:968-72. [PMID: 19405125 DOI: 10.1002/ijc.24363] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
38 Reilly KM. Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk. Brain Pathol 2009;19:121-31. [PMID: 19076777 DOI: 10.1111/j.1750-3639.2008.00236.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
39 Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA;  Brain Tumor Epidemiology Consortium. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113:1953-1968. [PMID: 18798534 DOI: 10.1002/cncr.23741] [Cited by in Crossref: 532] [Cited by in F6Publishing: 564] [Article Influence: 38.0] [Reference Citation Analysis]
40 Chang Z, Guo CL, Ahronowitz I, Stemmer-Rachamimov AO, MacCollin M, Nunes FP. A role for the p53 pathway in the pathology of meningiomas with NF2 loss. J Neurooncol 2009;91:265-70. [PMID: 18974932 DOI: 10.1007/s11060-008-9721-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
41 Meningioma. The Genetics and Molecular Biology of Neural Tumors. [DOI: 10.1007/978-1-59745-510-7_3] [Reference Citation Analysis]
42 Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet Cytogenet 2008;180:14-9. [PMID: 18068527 DOI: 10.1016/j.cancergencyto.2007.08.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
43 Bethke L, Murray A, Webb E, Schoemaker M, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Kosteljanetz M, Swerdlow A, Houlston R. Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 2008;100:270-6. [PMID: 18270339 DOI: 10.1093/jnci/djn004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
44 Barnholtz-Sloan JS, Kruchko C. Meningiomas: causes and risk factors. Neurosurg Focus 2007;23:E2. [PMID: 17961039 DOI: 10.3171/FOC-07/10/E2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
45 Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C, Kilkenny M, McKinney P, Modan B, Sadetzki S, Schüz J, Swerdlow A, Vrijheid M, Auvinen A, Berg G, Blettner M, Bowman J, Brown J, Chetrit A, Christensen HC, Cook A, Hepworth S, Giles G, Hours M, Iavarone I, Jarus-Hakak A, Klaeboe L, Krewski D, Lagorio S, Lönn S, Mann S, McBride M, Muir K, Nadon L, Parent ME, Pearce N, Salminen T, Schoemaker M, Schlehofer B, Siemiatycki J, Taki M, Takebayashi T, Tynes T, van Tongeren M, Vecchia P, Wiart J, Woodward A, Yamaguchi N. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol 2007;22:647-64. [PMID: 17636416 DOI: 10.1007/s10654-007-9152-z] [Cited by in Crossref: 192] [Cited by in F6Publishing: 199] [Article Influence: 12.8] [Reference Citation Analysis]